<?xml version="1.0" encoding="UTF-8"?>
<p>The pandemic coronavirus disease-19 (COVID-19) has pushed the global healthcare system to a crisis and the world continues to search out safe and effective treatment options for COVID-19.
 <xref rid="cit0007" ref-type="bibr">7</xref>,
 <xref rid="cit0008" ref-type="bibr">8</xref> Although thereâ€™s no conclusive evidence of their benefit, the globe continues the utilization of hydroxychloroquine or chloroquine, often together with a second-generation macrolide for the treatment on COVID-19.
 <xref rid="cit0009" ref-type="bibr">9</xref> Since in vitro studies and a preliminary clinical report suggested the efficacy of chloroquine for COVID-19-associated pneumonia, there is increasing interest in this old antimalarial drug.
 <xref rid="cit0010" ref-type="bibr">10</xref>
</p>
